Use of alcuronium in patients undergoing renal transplantation.
Alcuronium 0.16 mg kg-1 was used to provide neuromuscular blockade in patients with chronic renal failure undergoing renal transplantation. Relaxation was found to be adequate for intubation and surgery. There were minimal alterations to cardiovascular variables. The dose required was small, and complete reversal occurred with neostigmine. Although the number of patients is small, the drug may be of value as an alternative to tubocurarine or pancuronium in such patients.
D000293:Adolescent; D000328:Adult; D000443:Alcuronium / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007442:Intubation, Intratracheal; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation; D008297:Male; D013997:Time Factors; D014117:Toxiferine / Q000031:analogs & derivatives
D014117:Toxiferine; D000443:Alcuronium